<DOC>
	<DOCNO>NCT00600444</DOCNO>
	<brief_summary>The purpose trial investigate success rate punction vena subclavia ( 99 % retrospective study ) 15 % high success rate vena sectio ( 80 % retro prospective study ) implantation totally implantable access port .</brief_summary>
	<brief_title>PORTAS 2 , Comparing Venae Sectio Versus Punction Vena Subclavia Insertion Totally Implantable Access Port</brief_title>
	<detailed_description />
	<criteria>Age equal great 18 year Patients schedule primary elective implantation TIAP Participation another clinical trial could interfere primary endpoint study Lack compliance Impaired mental state language problem Patients know allergy contrast agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>permanent venous access</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>parenteral nutrition</keyword>
	<keyword>Patients benign and/or malignant disease demand safe permanent venous access , e.g . chemotherapy and/or parenteral nutrition</keyword>
	<keyword>benign disease</keyword>
	<keyword>malignant disease</keyword>
</DOC>